[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Illumina Inc (ILMN)

Illumina Inc (ILMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Illumina Inc 5200 ILLUMINA WAY SAN DIEGO CA 92122 USA

www.illumina.com Employees: 8,650 P: 858-202-4500 F: 858-202-4545

Sector:

Medical

Description:

Illumina Inc. is a life sciences company, which provides tools and integrated systems for analysis of genetic variation and function. Using its proprietary technologies, the company provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, and gene expression profiling of DNA and RNA. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic and consumer genomics companies. Illumina generates revenue from two segments - Product and Service. Product are primarily attributed to the partnerships and collaborations to develop distributable clinical in-vitro diagnostics for Illumina sequencers. Service include genotyping and sequencing services as well as instrument maintenance contracts.

Key Statistics

Overview:

Market Capitalization, $K 28,431,790
Enterprise Value, $K 28,503,790
Shares Outstanding, K 151,000
Float, K 146,621
% Float 97.10%
Short Interest, K 8,057
Short Float 5.34%
Days to Cover 4.51
Short Volume Ratio 0.63
% of Insider Shareholders 2.90%
% of Institutional Shareholders 89.42%

Financials:

Annual Sales, $ 4,343 M
Annual Net Income, $ 850,000 K
Last Quarter Sales, $ 1,159 M
Last Quarter Net Income, $ 207,000 K
EBIT, $ 893,000 K
EBITDA, $ 1,163 M

Growth:

1-Year Return 101.77%
3-Year Return 19.11%
5-Year Return -59.47%
5-Year Revenue Growth 34.08%
5-Year Earnings Growth 7.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.31 on 07/30/26
Next Earnings Date 10/29/26
Earnings Per Share ttm 5.15
EPS Growth vs. Prev Qtr 13.91%
EPS Growth vs. Prev Year 10.08%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 09/23/08

ILMN Ratios

Ratio
Price/Earnings ttm 37.50
Price/Earnings forward 36.06
Price/Earnings to Growth 2.72
Return-on-Equity % 29.84%
Return-on-Assets % 12.17%
Profit Margin % 19.57%
Debt/Equity 0.53
Price/Sales 6.72
Price/Cash Flow 28.76
Price/Book 10.28
Book Value/Share 18.79
Interest Coverage 11.75
60-Month Beta 1.45
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.